Rotavirus-Inspired Nanointerface Engineered Biosensors for All-in-One Cancer Diagnosis
- 16 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (1) , 461-469
Abstract
Ultrasensitive and population-scale cancer screening technologies are critical to reducing cancer mortality. However, the current qRT-PCR falls short in high-throughput screening of multiple cancers. Here, a rotavirus-inspired multicancer diagnosis system (RMDS) is developed via nanointerface engineering. RMDS employs Y-shaped DNA (YDNA) probes to encircle the graphene quantum dots (GQDs) for nanointerface modification. The biotransduction mechanisms at the nanointerface are systematically investigated. RMDS greatly enhances the transduction efficiency of biological analytes by optimizing the probe density and configuration. RMDS realizes ultrasensitive detection of the lung cancer KARS G12D mutation with a limit of detection (LoD) of 5.7 aM and the breast cancer-related AKT2 gene (LoD: 3.0 aM). The multiple chambers enable simultaneous diagnosis of multiple cancers and determination of cancer progression. Clinical validation shows RMDS can be a practical solution, which could complement or replace qRT-PCR and become the next-generation all-in-one tool for large-scale population cancer screening.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFB3603600)
- National Natural Science Foundation of China (62074008)
This publication has 48 references indexed in Scilit:
- Enhancing Histopathology Breast Cancer Detection and Classification with the Deep Ensemble Graph NetworkSN Computer Science, 2024
- A Contrast‐Enhanced Tri‐Modal MRI Technique for High‐Performance Hypoxia Imaging of Breast CancerSmall, 2024
- Multi‐Body Biomarker Entrapment System: An All‐Encompassing Tool for Ultrasensitive Disease Diagnosis and Epidemic ScreeningAdvanced Materials, 2023
- Amplification‐Free Detection of SARS‐CoV‐2 Down to Single Virus Level by Portable Carbon Nanotube BiosensorsSmall, 2023
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2022
- MoS2-based nanocomposites for cancer diagnosis and therapyBioactive Materials, 2021
- Synthesis, Applications, and Prospects of Graphene Quantum Dots: A Comprehensive ReviewSmall, 2021
- Cancer immunotherapy: Pros, cons and beyondBiomedicine & Pharmacotherapy, 2020
- The feasibility of using mutation detection in ctDNA to assess tumor dynamicsInternational Journal of Cancer, 2017
- Gold nanoparticles-decorated graphene field-effect transistor biosensor for femtomolar MicroRNA detectionBiosensors and Bioelectronics, 2015